Table 7 Comparison of laboratory data between subgroups
From: Effects of half-dose and full-dose GnRH antagonists on IVF-ET outcomes: a retrospective study
Subgroup | Subgroup A1(n = 107) | Subgroup A2(n = 73) | Subgroup B1(n = 42) | Subgroup B2(n = 94) | P |
|---|---|---|---|---|---|
Cetrorelix usage days | 3.52 ± 1.57 | 3.68 ± 1.68 | 3.21 ± 1.39 | 3.76 ± 1.73 | >0.05 |
Gn usage days | 9.71 ± 1.81 | 9.52 ± 2.83 | 9.29 ± 2.76 | 8.62 ± 2.51 | >0.05 |
Gn total | 2201.40 ± 896.53 | 2498.29 ± 811.80 | 2197.62 ± 973.51 | 2628.67 ± 972.67 | <0.05 |
retrieved oocytes | 8.37 ± 4.21 | 9.07 ± 3.95 | 5.88 ± 3.57 | 6.06 ± 3.63 | >0.05 |
fertilized oocytes | 5.38 ± 3.12 | 5.16 ± 3.31 | 3.64 ± 2.51 | 3.94 ± 2.64 | >0.05 |
available embryos | 2.85 ± 1.81 | 3.21 ± 2.24 | 2.33 ± 1.20 | 2.27 ± 1.42 | >0.05 |
superior-quality embryos | 0.86 ± 1.27 | 0.73 ± 0.93 | 0.64 ± 0.76 | 0.73 ± 1.00 | >0.05 |